AUGM vs. JCGI, MTU, AJOT, BVT, DGI9, ARR, TIGT, BPM, PEMB, and JZCP
Should you be buying Augmentum Fintech stock or one of its competitors? The main competitors of Augmentum Fintech include JPMorgan China Growth & Income (JCGI), Montanaro UK Smaller Companies (MTU), AVI Japan Opportunity Trust (AJOT), Baronsmead Venture Trust (BVT), Digital 9 Infrastructure (DGI9), Aurora (ARR), Troy Income & Growth (TIGT), B.P. Marsh & Partners (BPM), Pembroke VCT B (PEMB), and JZ Capital Partners (JZCP). These companies are all part of the "asset management" industry.
Augmentum Fintech (LON:AUGM) and JPMorgan China Growth & Income (LON:JCGI) are both small-cap financial services companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, community ranking, earnings, profitability, institutional ownership, media sentiment, valuation and risk.
In the previous week, Augmentum Fintech and Augmentum Fintech both had 2 articles in the media. JPMorgan China Growth & Income's average media sentiment score of 0.50 beat Augmentum Fintech's score of 0.00 indicating that JPMorgan China Growth & Income is being referred to more favorably in the news media.
50.5% of Augmentum Fintech shares are held by institutional investors. Comparatively, 17.0% of JPMorgan China Growth & Income shares are held by institutional investors. 5.5% of Augmentum Fintech shares are held by company insiders. Comparatively, 1.4% of JPMorgan China Growth & Income shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Augmentum Fintech received 43 more outperform votes than JPMorgan China Growth & Income when rated by MarketBeat users.
Augmentum Fintech has a net margin of 0.00% compared to JPMorgan China Growth & Income's net margin of -86.07%. Augmentum Fintech's return on equity of 0.00% beat JPMorgan China Growth & Income's return on equity.
Augmentum Fintech has higher earnings, but lower revenue than JPMorgan China Growth & Income. JPMorgan China Growth & Income is trading at a lower price-to-earnings ratio than Augmentum Fintech, indicating that it is currently the more affordable of the two stocks.
Summary
Augmentum Fintech beats JPMorgan China Growth & Income on 7 of the 10 factors compared between the two stocks.
Get Augmentum Fintech News Delivered to You Automatically
Sign up to receive the latest news and ratings for AUGM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AUGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Augmentum Fintech Competitors List
Related Companies and Tools
